End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.91 CNY | +2.65% |
|
-2.09% | -21.91% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.94 times its estimated earnings per share for the ongoing year.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-21.91% | 264M | - | ||
+8.00% | 185B | B- | ||
+31.86% | 158B | B- | ||
+33.21% | 113B | A- | ||
+2.28% | 64.32B | A- | ||
+21.14% | 55.66B | B+ | ||
+0.11% | 48.41B | B+ | ||
-6.76% | 37.82B | A | ||
+0.78% | 35.57B | - | ||
+11.28% | 28.12B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300562 Stock
- Ratings Guangdong Transtek Medical Electronics Co., Ltd